Targeted degradation of KRAS and induction of bystander effects by a modular bioPROTAC
{{output}}
Targeted protein degradation is a promising strategy for addressing oncogenic drivers that are difficult to inhibit with small molecules, such as KRAS. While bioPROTACs expand the range of targetable proteins, their clinical translation is limited by inefficie... ...
